SAN FRANCISCO, December 14, 2017 /PRNewswire/ --
The global veterinary vaccines market is
expected to reach USD 12.6 billion by
2025, according to a new report by Grand View Research, Inc. Rise
in the outbreak of livestock diseases, expanding livestock
population and increasing zoonotic diseases are driving the market
growth. Increasing awareness regarding commercially available
vaccines is pushing the adoption globally. However, higher costs
associated with storage is challenging the growth and restricting
the entry of new players.
(Logo:
http://photos.prnewswire.com/prnh/20160524/371361LOGO )
This market has emerged to be one of the profitable investment
options seeking attention and investments from both government and
non-government players. Rise in the number of pet owners and their
shifting focus towards healthy animal practices are some other
factors propelling the growth of the market. Government
intervention in distribution channel on the other hand, is
affecting the profitability of the veterinary vaccine
manufacturers. The bulk purchase and supply of livestock vaccines
by countries such as India and
Alaska that have large livestock
population are reducing the profit margins of the vaccine
manufacturers' through bulk pricing.
Browse full research report with TOC on
"Veterinary/Animal Vaccines Market Analysis By Product
(Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By
Animal Type (Companion Animal, Cattle, Poultry, Equine), And
Segment Forecasts, 2014 - 2025" at:
https://www.grandviewresearch.com/industry-analysis/veterinary-animal-vaccines-market
Further Key Findings From the Report Suggest:
- Attenuated vaccines emerged as the largest segment as a result
of the benefits such as improved effectivity and enhanced long-term
prevention
- Cattle vaccines accounted for the largest share in the animal
type segment owing to the rise in the demand for safe animal
products
- Companion animal vaccines segment is the fastest growing
segment owing to the increase in number of pet owners
worldwide
- North America dominated the
market with the largest share in 2016. Constantly rising awareness
regarding animal health and increasing commercialization of animal
products are facilitating dominance of the region during the
forecast period.
- Asia Pacific is projected to
witness swift growth during the forecast period owing to the speedy
adoption of veterinary vaccines for quality food products and
better animal health
- Key players including Zoetis, Virbac Inc. Indian Immunological
Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck
Animal Health and Biogenesis Bago dominated the global veterinary
vaccines market.
Browse related reports by Grand View Research:
- Spinal Fusion Bone Graft Substitutes Market
-https://www.grandviewresearch.com/industry-analysis/spinal-fusion-bone-graft-substitutes-market
- Anti-Counterfeit Pharmaceuticals and Cosmetics Packaging
Market -
https://www.grandviewresearch.com/industry-analysis/anti-counterfeit-pharmaceuticals-cosmetics-packaging-market
- Small Molecule Targeted Cancer Therapy Market -
https://www.grandviewresearch.com/industry-analysis/small-molecule-targeted-cancer-therapy-market
- Endocrinology Drugs Market -
https://www.grandviewresearch.com/industry-analysis/endocrinology-drugs-market
Grand View Research has segmented the global veterinary
vaccines market based on product, animal type and
region:
- Product Outlook (Revenue, USD Million, 2014 -
2025)
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Animal Type Outlook (Revenue, USD Million, 2014 -
2025)
- Companion Animal Vaccines.
- Canine
- Distemper
- Kennel cough (Parainfluenza)
- Parvovirus
- Canine herpes
- Lyme Disease
- Feline
- Feline calicivirus
- Peritonitis (FIP)
- Feline FIV
- Cattle Vaccines
- BRSV
- Enzootic Bronchopneu
- IBR
- BVD/MD
- Poultry Vaccines
- Bronchitis
- Avian Influenza
- Marek's Disease
- Newcastle Disease
- Pig Vaccines
- Porcine reproductive disease
- Swine Influenza
- Swine Pneumonia
- Equine Vaccines
- Encephalomyelitis
- Rhinopneumonitis
- Influenza (Horse Flu)
- Regional Outlook (Revenue, USD Million, 2014 -
2025)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Read Our Blog By Grand View Research:
https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company
provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant
and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: www.grandviewresearch.com
SOURCE Grand View Research, Inc.